title: AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.
authors.forename: Sidney C
authors.initials: SC
authors.lastname: Smith
authors.forename: Jerilyn
authors.initials: J
authors.lastname: Allen
authors.forename: Steven N
authors.initials: SN
authors.lastname: Blair
authors.forename: Robert O
authors.initials: RO
authors.lastname: Bonow
authors.forename: Lawrence M
authors.initials: LM
authors.lastname: Brass
authors.forename: Gregg C
authors.initials: GC
authors.lastname: Fonarow
authors.forename: Scott M
authors.initials: SM
authors.lastname: Grundy
authors.forename: Loren
authors.initials: L
authors.lastname: Hiratzka
authors.forename: Daniel
authors.initials: D
authors.lastname: Jones
authors.forename: Harlan M
authors.initials: HM
authors.lastname: Krumholz
authors.forename: Lori
authors.initials: L
authors.lastname: Mosca
authors.forename: Richard C
authors.initials: RC
authors.lastname: Pasternak
authors.forename: Thomas
authors.initials: T
authors.lastname: Pearson
authors.forename: Marc A
authors.initials: MA
authors.lastname: Pfeffer
authors.forename: Kathryn A
authors.initials: KA
authors.lastname: Taubert
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D003327:Coronary Disease / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D048909:Diabetes Complications; D006801:Humans; D006973:Hypertension / Q000150:complications; D007252:Influenza Vaccines; D050356:Lipid Metabolism; D012084:Renin-Angiotensin System / Q000502:physiology; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects
chemical_list: D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants; D007252:Influenza Vaccines